Export bans could jeopardise British swine flu vaccine supplies
Foreign governments could impose export bans as the swine flu pandemic worsens, jeopardising contracts for vaccine held with pharmaceutical companies abroad.
The US pharmaceutical company who are manufacturing the H1N1 swine flu vaccine for the UK, Baxter International, have said that it could not take anymore orders for H1N1 vaccines. It has already agreed to make a total of 80 million doses of the vaccine for 5 countries.
60 million doses of the swine flu vaccine are due to for delivery in the UK by the end of December. However, all of Britain's flu vaccines are produced abroad and there is expected to be some delay between the drugs being delivered from their production sites in Germany and people receiving their first vaccinations.
To full the article, please visit the Times Online website.